Sponsored Content | Webinar | Radiation Therapy| August 28, 2018

WEBINAR: Treating Tumors that Move: The Promise and Practice of Real-time MR Image Guidance During Radiation Beam Delivery

Respiratory tumor motion often complicates the delivery of precision radiation treatment. Over the past two decades, radiotherapy researchers and clinicians have pursued several approaches to motion management. However, the approaches lacked continuous, high-quality soft tissue visualization linked to an automated beam-gating technology that would see when a tumor moved out of margin range and halt the delivery of radiation until it returned to a prescribed area (PTV).

With the introduction of magnetic resonance image (MRI) guidance and real-time image guidance during beam delivery, the ability to lessen or eliminate radiation dose to surrounding tissues and organs is achievable. Several studies have demonstrated: (1) the ability to reduce to a minimum the margin expansion necessary to account for motion error while reducing doses to nearby organs at risk, and (2) the ability to obtain duty cycles equal to or greater than those common to conventional gating.

In this webinar, two speakers will share their clinical experience with this MRI-Guided RT technology.

This webinar took place Sept. 20, 2018 — Register to view the archive version the webinar

 

Presenters:

John Ng, M.D.
Assistant Professor and Director of Medical Student Education in Radiation Oncology at Weill Cornell Medicine
[email protected]

John Ng is a Board Certified Radiation Oncologist and Assistant Professor of Radiation Oncology at Weill Cornell Medical College/New York Presbyterian Hospital. Dr. Ng attended Columbia University and then received an M.S. degree in Biophysics from Harvard University. He obtained his M.D. degree from Harvard Medical School, jointly with the Massachusetts Institute of Technology, as part of the Health Sciences and Technology (HST) program. Joining Weill Cornell Medical Center, he serves as attending physician for Breast Oncology and for Gastrointestinal Oncology. His current focus is on exploring emerging radiation technologies such as magnetic resonance imaging (MRI) guided radiation as a way of amplifying the host immune response to cancer cells.

 

Kathryn Mittauer, Ph.D., DABR
Staff Medical Physicist at University of Wisconsin-Madison
[email protected]

Mittauer is a staff medical physicist and researcher at the University of Wisconsin-Madison. She has specialized in clinical implementation and coverage of MR-guided radiotherapy with the ViewRay MRIdian system since 2015. She has a master’s degree in medical physics from the University of Kentucky and a doctorate in medical physics from the University of Florida. She completed her residency in medical physics at the University of Wisconsin-Madison. Her research efforts include using online adaptive MR-guided radiotherapy to assess normal tissue toxicities and dose escalation strategies.

 

About ViewRay

ViewRay Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian’s high-definition MR was purposely built to address specific challenges, including beam distortion, skin toxicity and other concerns that may potentially arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay Inc.

 

Register to view the archive version the webinar

Related Content

News | Prostate Cancer

January 19, 2022 — For the first time, researchers led by a team from the UCLA Jonsson Comprehensive Cancer Center used ...

Time January 19, 2022
arrow
News | Lung Imaging

January 17, 2022 — A recent, substantial decline in lung cancer deaths is associated with earlier diagnosis of lung ...

Time January 17, 2022
arrow
News | Radiation Therapy

January 13, 2022 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance ...

Time January 13, 2022
arrow
News | Radiation Therapy

January 10, 2022 — Nanobiotix, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time January 10, 2022
arrow
News | Radiation Oncology

January 7, 2022 — Varian and parent company Siemens Healthineers have been recognized in the annual IMV ServiceTrak ...

Time January 07, 2022
arrow
News | Radiation Oncology

January 7, 2022 — A Case Western Reserve University-led team of scientists has used Artificial Intelligence (AI) to ...

Time January 07, 2022
arrow
News | Proton Therapy

January 3, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and ...

Time January 03, 2022
arrow
News | Radiation Oncology

December 30, 2021 — IBA (Ion Beam Applications S.A), a world leader in particle accelerator technology, announced the ...

Time December 30, 2021
arrow
News | Radiation Therapy

December 29, 2021 — Researchers at the University of Surrey have identified key design rules for making curved X-ray ...

Time December 29, 2021
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of December 2021. This is based ...

Time December 23, 2021
arrow
Subscribe Now